These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 985839)

  • 1. Enzymatic degradation of tumor cells damaged by antibody plus complement.
    Reif AE; Robinson CM
    J Immunol; 1976 Aug; 117(2):597-601. PubMed ID: 985839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assay of immune cytolysis of lymphocytes and tumour cells by automatic determination of cell volume distribution.
    Reif AE; Robinson CM; Incze JS
    Immunology; 1977 Jul; 33(1):69-80. PubMed ID: 873576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteinase activity and agglutination of leukemia cells.
    Kawiak J; Miks B
    Folia Histochem Cytochem (Krakow); 1979; 17(4):345-52. PubMed ID: 43819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A protease-like activity associated with malignant cells.
    Schnebli HP
    Schweiz Med Wochenschr; 1972 Aug; 102(33):1194-7. PubMed ID: 5055041
    [No Abstract]   [Full Text] [Related]  

  • 5. RNA polymerases and their stimulating factor from leukemia L1210 ascites cells.
    Tomioka H; Saito H
    Hiroshima J Med Sci; 1981 Jun; 30(2):93-7. PubMed ID: 7298366
    [No Abstract]   [Full Text] [Related]  

  • 6. Enzymes of creatine biosynthesis, arginine and methionine metabolism in normal and malignant cells.
    Bera S; Wallimann T; Ray S; Ray M
    FEBS J; 2008 Dec; 275(23):5899-909. PubMed ID: 19021765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrolytic cleavage of methotrexate gamma-polyglutamates by folylpolyglutamyl hydrolase derived from various tumors and normal tissues of the mouse.
    Samuels LL; Goutas LJ; Priest DG; Piper JR; Sirotnak FM
    Cancer Res; 1986 May; 46(5):2230-5. PubMed ID: 2421872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymidylate synthetase and thymidine kinase activities and methotrexate cytotoxicity during growth of L1210 and Ehrlich ascites tumor.
    Hullán L; Szikla K; Tusnády G; Holczinger L
    Cancer Biochem Biophys; 1988 Nov; 10(2):131-9. PubMed ID: 3252959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous proteolytic activity of chromatin.
    Anachkova B; Russev G
    Acta Biol Med Ger; 1977; 36(11-12):1945-50. PubMed ID: 616741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased susceptibility of carbamylated glutamate dehydrogenase to proteolysis.
    Hood W; de la Morena E; Grisolia S
    Acta Biol Med Ger; 1977; 36(11-12):1667-72. PubMed ID: 616712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteolytic activity associated with tumour growth and metastasis. Influence of trypsin inhibitor (soya bean) on Ehrlich ascites tumour growth [proceedings].
    Verloes R; Kanarek L
    Arch Int Physiol Biochim; 1976 Dec; 84(5):1119-20. PubMed ID: 66028
    [No Abstract]   [Full Text] [Related]  

  • 12. Isolation and purification of phosphate dependent glutaminase from sarcoma-180 tumor and its antineoplastic effects on murine model system.
    Maity P; Chakraborty S; Bhattacharya P; Sarkar R
    J Exp Clin Cancer Res; 1999 Dec; 18(4):475-80. PubMed ID: 10746973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential antigenic expression of the DBA/2 lymphoma L1210 and its sublines: cross-reactivity with C3H mammary tumors as defined by syngeneic monoclonal antibodies.
    Rapp L; Fuji H
    Cancer Res; 1983 Jun; 43(6):2592-9. PubMed ID: 6342755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor cell metastasis and surface neutral proteinase: effects of antimetastatic and antitumor drugs.
    Giraldi T; Sava G; Perissin L; Zorzet S; Decorti G; Steven FS
    Invasion Metastasis; 1985; 5(6):336-43. PubMed ID: 3905687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibodies to the L1210 murine leukemia cell line and to a drug-altered subline.
    Testorelli C; Archetti YL; Aresca P; Del Vecchio L
    Cancer Res; 1985 Nov; 45(11 Pt 1):5299-303. PubMed ID: 4053006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteolytic activity in liver cells from mouse, rat, Ehrlich ascites carcinoma bearing mouse and in Ehrlich ascites carcinoma cells.
    Tekavcic E; Skrk J; Suhar A; Lebez D
    Neoplasma; 1976; 23(5):515-22. PubMed ID: 10531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A naturally occurring complement dependent human IgM macroglobulin inhibitory to Ehrlich ascites tumor cells.
    Goff MM; Armentrout SA
    J Clin Lab Immunol; 1982 Dec; 9(3):163-7. PubMed ID: 7166749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition properties of Sepharose-bound trypsin and a protease on the surface of Ehrlich ascites tumour cells.
    Steven FS; Griffin MM; Itzhaki GS; Al-Habib A
    Biochim Biophys Acta; 1981 Aug; 660(2):333-40. PubMed ID: 6269636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Proteolytic enzymes of malignant tissues (author's transl)].
    Farbiszewski R; Worowski K
    Postepy Biochem; 1975; 21(4):407-23. PubMed ID: 241983
    [No Abstract]   [Full Text] [Related]  

  • 20. Characterization of putative nuclear pre-messenger RNA of Ehrlich ascites tumor cells.
    Nakai GS; Omiecznski D
    Biomedicine; 1975 Sep; 22(5):399-403. PubMed ID: 1241293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.